Sudeep Pharma IPO
Open MainLineCurrent GMP
₹121 (+20.40%)
Price Band
₹ 563 – 593
Lot Size
25
Issue Size
₹895 Cr
Minimum Investment
₹14825 (25 Shares)
Listing Date
28 November 2025
Subscription
93.72x
About the Company
Sudeep Pharma Limited, incorporated in 1989, is a leading manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients, supplying products to over 100 countries.
Operations
- The company operates six manufacturing facilities with a combined production capacity of 50,000 MT.
- It specializes in producing high-quality mineral salts, including calcium, iron, magnesium, zinc, potassium, and sodium derivatives.
- With a portfolio of more than 200 products, Sudeep Pharma serves a diverse clientele across the pharmaceutical, food, and nutrition industries.
Research & Development
- The company has strong R&D capabilities supported by in-house laboratories and pilot-scale production facilities.
- Its R&D efforts focus on innovation in mineral salts, pharmaceutical excipients, and specialty ingredients.
Product Portfolio
- Pharmaceutical, Food, and Nutrition Business
- Specialty Ingredients Business
- Triturates
Human Resources
- As of December 31, 2024, Sudeep Pharma Limited employed 704 permanent employees.
Promoters
- Sujit Jaysukh Bhayani
- Shanil Sujit Bhayani
- Avani Sujit Bhayani
- Sujeet Jaysukh Bhayani HUF
- Riva Resources Private Limited
- Bhayani Family Trust
Promoters Holding
Holding Pre Issue
89.37%
Holding Post Issue
76.15%
Objects of the Issue
The Company Sudeep Pharma IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Capital expenditure towards procurement of machinery for our production line located at Nandesari Facility I
- General corporate purpose
Address / Contact Info
Sudeep Pharma Ltd.
129/1/A,
GIDC Estate,Nandesari,
Vadodara, Gujarat, 391340
Phone: +91 265 284 0656
Email: cs.sudeep@sudeepgroup.com
Website: https://www.sudeeppharma.com/
IPO Snapshot
IPO Timeline (Tentative)
IPO Open Date
Friday, 21 November 2025
IPO Close Date
Tuesday, 25 November 2025
Basis of Allotment
Wednesday, 26 November 2025
Initiation of Refunds
Thursday, 27 November 2025
Credit of Shares to Demat
Thursday, 27 November 2025
Listing Date
Friday, 28 November 2025 — NSE & BSE
Important Dates
Open Date
21 November 2025
Close Date
25 November 2025
Basis Of Allotment
26 November 2025
Listing Date
28 November 2025
Financial Performance (₹ in Crores)
| Particular | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 922.26 | 717.17 | 513.87 | 420.11 |
| Revenue | 130.08 | 511.33 | 465.38 | 438.26 |
| Profit After Tax | 31.27 | 138.69 | 133.15 | 62.32 |
| Net Worth | 688.32 | 497.53 | 359.07 | 226.29 |
| Reserve & Surplus | 668.52 | 481.11 | 354.59 | 221.88 |
| Total Borrowings | 135.97 | 135.25 | 75.03 | 82.26 |
EPS Pre
12.46%
EPS Post
11.07%
P/E Pre
47.61
P/E (Post Issue)
53.55x
Company Financial Information
KPI Information (₹ in Crores)
| Particular | KPI as of Mon | Mar 2024 | Mar 2023 |
|---|---|---|---|
| ROE % | 0 | 0 | 0 |
| ROCE % | 0 | 0 | 0 |
| Debt / Equity | 0.2 | 0.17 | 0.32 |
| RoNW % | 27.88 | 27.91 | 30.59 |
| PbW | 0 | 0 | 0 |
| Pat Margin % | 27.63 | 37.09 | 27.54 |
Return Ratio
IPO Reservations
| Category | Shares Offered | Shares Offered % | Max Allotee |
|---|---|---|---|
| Qualified Institutions | 3018550 | 28.57 | 0 |
| Non-Institutional | 2263913 | 21.43 | 0 |
| BNII | 1509276 | 14.29 | 0 |
| SNII | 754637 | 7.14 | 0 |
| Retail Investors | 5282463 | 50 | 0 |
| Total | 10564926 | 100 | 0 |
Subscription Status ( Tue, 25 Nov 25 01:34 PM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 3018550 | 643188450 | 213.08x |
| Non-Institutional | 2263913 | 264240450 | 116.72x |
| BNII | 1509276 | 203619700 | 134.91x |
| SNII | 754637 | 60620750 | 80.33x |
| Retail Investors | 5282463 | 82671250 | 15.65x |
| Total | 10564926 | 990100150 | 93.72x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Peer Comparision
No Peer Comparision Available
Lot Size & Investment Details
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 25 | 14,825.00 |
| Retail (Max) | 13 | 325 | 192,725.00 |
| S-HNI (Min) | 14 | 350 | 207,550.00 |
| S-HNI (Max) | 67 | 1,675 | 993,275.00 |
| B-HNI (Min) | 68 | 1,700 | 1,008,100.00 |
Registrar
MUFG Intime India Private Limited ((Link Intime)
91-22-4918 6270
ipo.helpdesk@in.mpms.mufg.com
https://in.mpms.mufg.com/home.html
Book Running Lead Managers
- ICICI Securities Limited
- IIFL Capital Services Limited
RHP Document
DRHP Document
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Sudeep Pharma IPO is a Book-building IPO worth ₹895 crores. The price band is ₹563 to 593 per share. The IPO opens on Fri, Nov 21, 2025 and closes on Tue, Nov 25, 2025. It will be listed on BSE and NSE. MUFG Intime India Private Limited ((Link Intime) is the registrar.
The Sudeep Pharma IPO opens on Fri, Nov 21, 2025 and closes on Tue, Nov 25, 2025
Sudeep Pharma IPO Price Band is ₹563 to 593.
Sudeep Pharma IPO lot size is 25, and the minimum amount required for application is ₹14825.
The minimum investment for Sudeep Pharma IPO is approximately ₹14825 based on the upper price band.
To apply for the Sudeep Pharma IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of Tue, Nov 25, 2025. After submission, funds are blocked until the basis of allotment of Sudeep Pharma IPO is finalised.
Sudeep Pharma IPO issue size is ₹895 crores.
Sudeep Pharma IPO allotment date is Sat, Jun 27, 2026.
The registrar for Sudeep Pharma IPO is MUFG Intime India Private Limited ((Link Intime). Investors can go to MUFG Intime India Private Limited ((Link Intime) website for IPO allotment status, refund processing, and other queries related to Sudeep Pharma IPO through their official website or helpline.
The Sudeep Pharma IPO GMP (Grey Market Premium) is ₹121 as of Fri, Nov 28, 2025. Based on the upper price band of ₹593 per share, the estimated Sudeep Pharma IPO listing price is ₹714, indicating a potential listing gain of approximately 31% over the issue price.